About Carmell Company
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasmabased bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company is headquartered in Pittsburgh, PA.
Carmell(CTCX.US) 10% Shareholder Buys US$38,053.1 in Common Stocks
$Carmell(CTCX.US)$ 10% Shareholder Shukla Rajiv purchased 13,617 shares of Common Stocks on Nov 28, 29, 30, Dec 1, 2023 at an average price of $2.7945 for a total value of $38,053.1.Source: Announceme
Carmell(CTCX.US) Officer Buys US$4,275 in Common Stocks
$Carmell(CTCX.US)$ Officer Cassaday Bryan J. purchased 1,500 shares of Common Stocks on Nov 28, 2023 at an average price of $2.85 for a total value of $4,275.Source: Announcement What is statement of
Carmell CEO Buys Shares Worth Over $15.5k - Filing